This chapter covers the emergent management of anticonvulsant toxicities, focusing on phenytoin, carbamazepine, and valproic acid. Understanding their unique mechanisms, diagnostics, and targeted therapies is crucial for board exams to ensure patient stabilization and specific antidote administratio
